Cargando…

Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature

BACKGROUND: Aging is accompanied by increasing vulnerability to pathologies such as atherosclerosis (ATH) and Alzheimer disease (AD). Are these different pathologies, or different presentations with a similar underlying pathoetiology? DISCUSSION: Both ATH and AD involve inflammation, macrophage infi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lathe, Richard, Sapronova, Alexandra, Kotelevtsev, Yuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994432/
https://www.ncbi.nlm.nih.gov/pubmed/24656052
http://dx.doi.org/10.1186/1471-2318-14-36
_version_ 1782312725555183616
author Lathe, Richard
Sapronova, Alexandra
Kotelevtsev, Yuri
author_facet Lathe, Richard
Sapronova, Alexandra
Kotelevtsev, Yuri
author_sort Lathe, Richard
collection PubMed
description BACKGROUND: Aging is accompanied by increasing vulnerability to pathologies such as atherosclerosis (ATH) and Alzheimer disease (AD). Are these different pathologies, or different presentations with a similar underlying pathoetiology? DISCUSSION: Both ATH and AD involve inflammation, macrophage infiltration, and occlusion of the vasculature. Allelic variants in common genes including APOE predispose to both diseases. In both there is strong evidence of disease association with viral and bacterial pathogens including herpes simplex and Chlamydophila. Furthermore, ablation of components of the immune system (or of bone marrow-derived macrophages alone) in animal models restricts disease development in both cases, arguing that both are accentuated by inflammatory/immune pathways. We discuss that amyloid β, a distinguishing feature of AD, also plays a key role in ATH. Several drugs, at least in mouse models, are effective in preventing the development of both ATH and AD. Given similar age-dependence, genetic underpinnings, involvement of the vasculature, association with infection, Aβ involvement, the central role of macrophages, and drug overlap, we conclude that the two conditions reflect different manifestations of a common pathoetiology. MECHANISM: Infection and inflammation selectively induce the expression of cholesterol 25-hydroxylase (CH25H). Acutely, the production of ‘immunosterol’ 25-hydroxycholesterol (25OHC) defends against enveloped viruses. We present evidence that chronic macrophage CH25H upregulation leads to catalyzed esterification of sterols via 25OHC-driven allosteric activation of ACAT (acyl-CoA cholesterol acyltransferase/SOAT), intracellular accumulation of cholesteryl esters and lipid droplets, vascular occlusion, and overt disease. SUMMARY: We postulate that AD and ATH are both caused by chronic immunologic challenge that induces CH25H expression and protection against particular infectious agents, but at the expense of longer-term pathology.
format Online
Article
Text
id pubmed-3994432
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39944322014-04-23 Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature Lathe, Richard Sapronova, Alexandra Kotelevtsev, Yuri BMC Geriatr Debate BACKGROUND: Aging is accompanied by increasing vulnerability to pathologies such as atherosclerosis (ATH) and Alzheimer disease (AD). Are these different pathologies, or different presentations with a similar underlying pathoetiology? DISCUSSION: Both ATH and AD involve inflammation, macrophage infiltration, and occlusion of the vasculature. Allelic variants in common genes including APOE predispose to both diseases. In both there is strong evidence of disease association with viral and bacterial pathogens including herpes simplex and Chlamydophila. Furthermore, ablation of components of the immune system (or of bone marrow-derived macrophages alone) in animal models restricts disease development in both cases, arguing that both are accentuated by inflammatory/immune pathways. We discuss that amyloid β, a distinguishing feature of AD, also plays a key role in ATH. Several drugs, at least in mouse models, are effective in preventing the development of both ATH and AD. Given similar age-dependence, genetic underpinnings, involvement of the vasculature, association with infection, Aβ involvement, the central role of macrophages, and drug overlap, we conclude that the two conditions reflect different manifestations of a common pathoetiology. MECHANISM: Infection and inflammation selectively induce the expression of cholesterol 25-hydroxylase (CH25H). Acutely, the production of ‘immunosterol’ 25-hydroxycholesterol (25OHC) defends against enveloped viruses. We present evidence that chronic macrophage CH25H upregulation leads to catalyzed esterification of sterols via 25OHC-driven allosteric activation of ACAT (acyl-CoA cholesterol acyltransferase/SOAT), intracellular accumulation of cholesteryl esters and lipid droplets, vascular occlusion, and overt disease. SUMMARY: We postulate that AD and ATH are both caused by chronic immunologic challenge that induces CH25H expression and protection against particular infectious agents, but at the expense of longer-term pathology. BioMed Central 2014-03-21 /pmc/articles/PMC3994432/ /pubmed/24656052 http://dx.doi.org/10.1186/1471-2318-14-36 Text en Copyright © 2014 Lathe et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Debate
Lathe, Richard
Sapronova, Alexandra
Kotelevtsev, Yuri
Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature
title Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature
title_full Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature
title_fullStr Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature
title_full_unstemmed Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature
title_short Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature
title_sort atherosclerosis and alzheimer - diseases with a common cause? inflammation, oxysterols, vasculature
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994432/
https://www.ncbi.nlm.nih.gov/pubmed/24656052
http://dx.doi.org/10.1186/1471-2318-14-36
work_keys_str_mv AT latherichard atherosclerosisandalzheimerdiseaseswithacommoncauseinflammationoxysterolsvasculature
AT sapronovaalexandra atherosclerosisandalzheimerdiseaseswithacommoncauseinflammationoxysterolsvasculature
AT kotelevtsevyuri atherosclerosisandalzheimerdiseaseswithacommoncauseinflammationoxysterolsvasculature